Celltech Collaborates With University Of Durham And Oxford Instruments To Pioneer New Magnetotherapy Technology
22-Nov-2004 -
Celltech Antibody Centre of Excellence, part of UCB, has joined forces with the University of Durham and Oxford Instruments Molecular Biotools Ltd to develop the first UK antibody-targeted magnetotherapy technology; a potentially new approach for cancer therapy. This alliance, which is based on a ...
antibodies
apoptosis
cancer therapy
+3